ELVIN A HOLSTIUS
Pharmacy in Greenville, NC
License number
North Carolina RPH01085
Issued Date
Sep 3, 1943
Expiration Date
6, 1988
Category
Pharmacy
Type
Pharmacist
Address
Address
Greenville, NC
Education
RI, Jan 6, 1943
Professional information
Method And Preparation For Increasing Bioavailability Of Digoxin
US Patent:
4088750, May 9, 1978
Filed:
Jan 28, 1976
Appl. No.:
5/653246
Inventors:
Ronald M. Cresswell - Raleigh NC
Elvin A. Holstius - Greenville NC
Elvin A. Holstius - Greenville NC
Assignee:
Burroughs Wellcome Co. - Research Triangle Park NC
International Classification:
A61K 948, A61K 31705
US Classification:
424 37
Abstract:
Method and preparation for increasing the bioavailability of digoxin to treat cardiac insufficiency in a human, said method comprising the administration of a preparation comprising a capsule adapted to release a solution of digoxin in an amount sufficient to treat cardiac insufficiency.
Chemotherapeutic Solutions Containing A Sulphur And A Salt Of A 2,4-Diamino-5-Benzylpyrimidine
US Patent:
3985876, Oct 12, 1976
Filed:
May 7, 1975
Appl. No.:
5/575142
Inventors:
John R. Hazlett - Greenville NC
Elvin A. Holstius - Greenville NC
Elvin A. Holstius - Greenville NC
Assignee:
Burroughs Wellcome Co. - Research Triangle Park NC
International Classification:
A61K 3163, A61K 31635
US Classification:
424229
Abstract:
A clear solution suitable for oral or parenteral chemotherapy of microbial, especially bacterial, infections containing a sulfonamide in an organic solvent and a mono acid addition salt of a sulfonamide potentiator (e. g. trimethoprim) in water, the solution having a pH in the range 2 to 7.
Solution Containing Trimethoprim, Sulfacetamide And Polymyxin
US Patent:
3985873, Oct 12, 1976
Filed:
Apr 18, 1975
Appl. No.:
5/569412
Inventors:
George E. Alvan - Greenville NC
Elvin A. Holstius - Greenville NC
Elvin A. Holstius - Greenville NC
Assignee:
Burroughs Wellcome Co. - Research Triangle Park NC
International Classification:
A61K 3700, A61K 3163, A61K 31505
US Classification:
424177
Abstract:
Ophthalmic solution suitable for treatment of microbial, especially bacterial, infections of and around the eye containing sulfacetamide, a medicinally or pharmaceutically acceptable water soluble mono salt of trimethoprim, a medicinally or pharmaceutically acceptable water soluble salt of polymyxin, especially polymyxin B, and water, the solution having a pH in the range of 4. 5 to 6. 5 with 5 to 6 being preferred.